Bioscience Animal Health Public Company Limited(TH:BIS)
฿2.16-0.08 (-3.57%)
TH:BIS
Bioscience Animal Health Public Company Limited financials statements
฿2.16
At close:-0.08 (-3.57%)
Bioscience Animal Health Public Company Limited (BIS) Ratios
Bioscience Animal Health Public Company Limited Ratios
TH:BIS's free cash flow for Q2 2026 was ฿-20.41M. For the 2026 fiscal year, TH:BIS's free cash flow was decreased by ฿-424.00K and operating cash flow was ฿-19.98M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.36 | 2.42 | 2.41 | 2.79 | 1.19 |
| Quick Ratio | 1.82 | 1.80 | 1.59 | 1.87 | 0.82 |
| Cash Ratio | 0.12 | 0.30 | 0.06 | 0.07 | 0.12 |
| Solvency Ratio | 0.13 | 0.19 | 0.15 | 0.23 | 0.14 |
| Operating Cash Flow Ratio | 0.62 | 0.25 | -0.05 | -0.11 | 0.06 |
| Short-Term Operating Cash Flow Coverage | 16131.00 | 2.37 | 0.00 | 0.00 | 0.14 |
| Net Current Asset Value | ฿ 586.04M | ฿ 580.34M | ฿ 586.01M | ฿ 531.80M | ฿ 67.94M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.04 | 0.01 | 0.01 | 0.34 |
| Debt-to-Equity Ratio | 0.01 | 0.07 | 0.01 | 0.01 | 1.17 |
| Debt-to-Capital Ratio | 0.01 | 0.07 | 0.01 | 0.01 | 0.54 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 |
| Financial Leverage Ratio | 1.61 | 1.56 | 1.57 | 1.43 | 3.46 |
| Debt Service Coverage Ratio | 23.16 | 1.99 | 37.74 | 13.03 | 0.34 |
| Interest Coverage Ratio | 16.52 | 36.05 | 36.19 | 13.09 | 9.68 |
| Debt to Market Cap | 0.00 | 0.05 | 0.00 | 0.00 | 0.23 |
| Interest Debt Per Share | 0.02 | 0.19 | 0.03 | 0.05 | 1.46 |
| Net Debt to EBITDA | -1.14 | -0.64 | -0.22 | -0.16 | 2.10 |
| Profitability Margins | |||||
| Gross Profit Margin | 15.18% | 14.88% | 13.80% | 14.44% | 17.57% |
| EBIT Margin | 0.88% | 4.08% | 2.83% | 3.74% | 4.89% |
| EBITDA Margin | 1.80% | 4.89% | 3.51% | 4.45% | 5.77% |
| Operating Profit Margin | 0.88% | 4.08% | 2.83% | 3.74% | 4.87% |
| Pretax Profit Margin | 2.44% | 3.97% | 2.75% | 3.45% | 4.39% |
| Net Profit Margin | 1.71% | 2.80% | 2.10% | 2.55% | 3.67% |
| Continuous Operations Profit Margin | 1.90% | 3.08% | 2.19% | 2.72% | 3.46% |
| Net Income Per EBT | 69.89% | 70.54% | 76.36% | 73.80% | 83.61% |
| EBT Per EBIT | 277.07% | 97.23% | 97.24% | 92.36% | 89.98% |
| Return on Assets (ROA) | 3.06% | 5.19% | 4.13% | 5.15% | 7.88% |
| Return on Equity (ROE) | 4.91% | 8.11% | 6.50% | 7.35% | 27.27% |
| Return on Capital Employed (ROCE) | 2.44% | 11.39% | 8.49% | 10.50% | 30.70% |
| Return on Invested Capital (ROIC) | 1.89% | 8.36% | 6.74% | 8.24% | 13.01% |
| Return on Tangible Assets | 3.07% | 5.22% | 4.15% | 5.17% | 7.89% |
| Earnings Yield | 6.25% | 7.05% | 3.34% | 2.48% | 5.49% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.18 | 4.63 | 4.78 | 5.22 | 4.83 |
| Payables Turnover | 4.72 | 6.20 | 5.43 | 6.79 | 5.37 |
| Inventory Turnover | 7.98 | 7.47 | 5.96 | 6.73 | 7.19 |
| Fixed Asset Turnover | 20.38 | 18.62 | 19.72 | 18.08 | 15.74 |
| Asset Turnover | 1.79 | 1.86 | 1.96 | 2.02 | 2.15 |
| Working Capital Turnover Ratio | 3.75 | 3.88 | 4.22 | 6.66 | 21.00 |
| Cash Conversion Cycle | 38.85 | 68.77 | 70.42 | 70.46 | 58.26 |
| Days of Sales Outstanding | 70.42 | 78.75 | 76.43 | 69.95 | 75.50 |
| Days of Inventory Outstanding | 45.74 | 48.85 | 61.23 | 54.26 | 50.78 |
| Days of Payables Outstanding | 77.32 | 58.83 | 67.24 | 53.74 | 68.01 |
| Operating Cycle | 116.17 | 127.60 | 137.66 | 124.20 | 126.28 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.87 | 0.33 | -0.07 | -0.12 | 0.17 |
| Free Cash Flow Per Share | 0.87 | 0.31 | -0.10 | -0.18 | 0.08 |
| Dividend Paid and CapEx Coverage Ratio | 4.94 | 2.33 | -0.56 | -0.26 | 0.88 |
| Capital Expenditure Coverage Ratio | 127.13 | 14.84 | -2.68 | -1.86 | 1.84 |
| Operating Cash Flow Coverage Ratio | 44.32 | 1.87 | -3.29 | -4.94 | 0.12 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.04 | -0.01 | -0.01 | 0.02 |
| Free Cash Flow Yield | 44.21% | 10.55% | -2.04% | -2.23% | 1.27% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 16.33 | 14.00 | 30.25 | 39.75 | 18.18 |
| Price-to-Sales (P/S) Ratio | 0.27 | 0.40 | 0.63 | 1.03 | 0.67 |
| Price-to-Book (P/B) Ratio | 0.79 | 1.15 | 1.95 | 2.96 | 4.97 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 2.26 | 9.48 | -49.08 | -44.79 | 78.69 |
| Price-to-Operating Cash Flow Ratio | 2.24 | 8.84 | -67.36 | -68.87 | 35.94 |
| Price-to-Earnings Growth (PEG) Ratio | -0.38 | 0.45 | -1.51 | -1.01 | -0.36 |
| Enterprise Value Multiple | 14.04 | 7.50 | 17.72 | 22.90 | 13.69 |
| Enterprise Value | 569.33M | 851.04M | 1.50B | 2.24B | 1.56B |
| EV to EBITDA | 14.04 | 7.50 | 17.72 | 22.90 | 13.69 |
| EV to Sales | 0.25 | 0.37 | 0.62 | 1.02 | 0.79 |
| EV to Free Cash Flow | 2.09 | 8.74 | -48.48 | -44.48 | 92.97 |
| EV to Operating Cash Flow | 2.08 | 8.15 | -66.54 | -68.38 | 42.46 |
| Tangible Book Value Per Share | 2.53 | 2.57 | 2.50 | 2.69 | 1.20 |
| Shareholders’ Equity Per Share | 2.49 | 2.55 | 2.48 | 2.68 | 1.21 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.22 | 0.20 | 0.21 | 0.21 |
| Revenue Per Share | 7.18 | 7.40 | 7.68 | 7.74 | 8.98 |
| Net Income Per Share | 0.12 | 0.21 | 0.16 | 0.20 | 0.33 |
| Tax Burden | 0.70 | 0.71 | 0.76 | 0.74 | 0.84 |
| Interest Burden | 2.77 | 0.97 | 0.97 | 0.92 | 0.90 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.14 | 0.13 | 0.12 | 0.12 | 0.13 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 6.41 | 1.46 | -0.44 | -0.55 | 0.54 |
Currency in THB
